Cell adhesion molecules, plasminogen activator inhibitor type 1, and metabolic syndrome in patients with psoriasis

Teixeira, GG; Mari, NL; de Paula, JCC; Cataldi de Alcantara, C; Flauzino, T; Lozovoy, MAB; Martin, LMM; Reiche, EMV; Maes, M; Dichi, I; Simão, ANC

File(s) not publicly available

Cell adhesion molecules, plasminogen activator inhibitor type 1, and metabolic syndrome in patients with psoriasis

Version 2 2024-06-05, 05:05

Version 1 2023-10-24, 22:04

journal contribution

posted on 2024-06-05, 05:05 authored by GG Teixeira, NL Mari, JCC de Paula, C Cataldi de Alcantara, T Flauzino, MAB Lozovoy, LMM Martin, EMV Reiche, M Maes, I Dichi, ANC Simão

Cell adhesion molecules, plasminogen activator inhibitor type 1, and metabolic syndrome in patients with psoriasis

History

Journal

Clinical and Experimental Medicine

Volume

20

Pagination

39-48

Location

Berlin, Germany

Publisher DOI

https://doi.org/10.1007/s10238-019-00595-2

ISSN

1591-8890

eISSN

1591-9528

Language

eng

Publication classification

C1 Refereed article in a scholarly journal

Issue

1

Publisher

Springer

Usage metrics

Keywords

Psoriasis Cellular adhesion molecules Metabolic syndrome Plasminogen activator inhibitor type 1 Carbohydrate metabolism Adult Biomarkers Cell Adhesion Molecules Endothelial Cells Female Humans Male Metabolic Syndrome Middle Aged Plasminogen Activator Inhibitor 1 Sensitivity and Specificity

Licence

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

File(s) not publicly available

Cell adhesion molecules, plasminogen activator inhibitor type 1, and metabolic syndrome in patients with psoriasis

History

Journal

Volume

Pagination

Location

Publisher DOI

ISSN

eISSN

Language

Publication classification

Issue

Publisher

Usage metrics

Categories

Keywords

Licence

Exports